The following guideline can be ordered through the address listed in the "Source/Publisher"-category. In cases in which you can order through the Internet we have established a hyperlink.

FDA Guidance for Industry: Residual Solvents in Drug Products Marketed in the United States



This guidance is intended to assist manufacturers in responding to the issuance of a new USP test requirement for the control of residual solvents in drug products marketed in the United States.

Go back

GMP Conferences by Topics

Cookies help us in providing our services. By using our services, you agree that we use cookies. Further information